Status:
RECRUITING
A Cohort Establishment Study of Total Management of Ovarian Cancer
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Conditions:
Tumor of Female Reproductive System
Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).
Detailed Description
1. To investigate the effects of surgery, chemotherapy, maintenance therapy and related factors on the prognosis and quality of life of patients with ovarian cancer (including fallopian tube cancer an...
Eligibility Criteria
Inclusion
- Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital;
- Can cooperate with later follow-up.
Exclusion
- Patients with other malignant tumors or previous history of other malignant tumors;
- Have cognitive impairment.
Key Trial Info
Start Date :
June 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06018935
Start Date
June 17 2024
End Date
September 1 2025
Last Update
June 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sichuan Cancer Hospital
Chengdu, China